Halozyme shares jump after FDA lifts hold on trialReutersJune 5 (Reuters) – Shares of Halozyme Therapeutics Inc jumped about 11 percent a day after the U.S. Food and Drug Administration lifted a hold on a trial testing an advanced version of the company’s flagship drug delivery technology. The company said on …Ahead of the Bell: Halozyme Therapeutics soarsBusinessweekHalozyme Therapeutics (HALO) Moving On Heavy Pre-Market TradingTheStreet.comMorning Market MoversBenzingaMotley Fool -Bidness Etc -RTT Newsall 22 news articles …Read Full Story
Halozyme shares jump after FDA lifts hold on trial - Reuters
Real Estate of Cebu
